Cerenis Therapeutics Gets $10 M For Second Close Of Series C Funding Round
Cerenis Therapeutics raised another €10 million in a second close of its Series C financing. The Toulouse, France-based developer of cardiovascular and other metabolic diseases treatments secured a total of €50 million for the round. Its total equity investment raised-to-date stands at €117 million. The latest €10 million came from the group IRDI-IXO (€2.5 million each) and other unnamed investors.
21 October 2010•3 mins read
